TGFB1 and metastatic neoplasm: Recent data suggests that aberrant activation of MAPK pathways may play an important role in diverting the TGF-β response towards a pro-oncogenic outcome, and that TGF-β and activated Ras may cooperate to promote invasive, metastatic disease (Park et al, 2000).